新型精神活性物质:加拿大对临床实验室新兴趋势和挑战的看法
Jessica J Miller1, Mehrdad Yazdanpanah2, David A Colantonio3
1Laboratory Medicine Program, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada.
Clinical biochemistry
|August 24, 2024
概括
新型精神活性物质 (NPS) 或"合法高",由于其多样化的结构和不断的修改,越来越难以检测. 本综述详细介绍了NPS类,它们的机制以及改善毒素监测的分析局限性.
科学领域:
- 法医毒理学 法医毒理学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 新型精神活性物质 (NPS) 由于快速演变和规范规避而构成全球性挑战.
- NPS模仿受控物质,导致不可预测的精神活性作用和公共卫生风险.
研究的目的:
- 审查NPS类,它们的作用机制,结构和代谢途径.
- 突出最近的NPS趋势和新出现的威胁,重点关注加拿大毒品趋势.
- 探索临床实验室对NPS检测的分析挑战和局限性.
主要方法:
- 基于药理作用的NPS分类的文献综述 (大麻模拟剂,抑郁剂,解离剂,幻觉剂,阿片类药物,兴奋剂).
- 在NPS类中分析结构多样性和常见的代谢途径.
- 检查当前的分析技术及其在临床毒理学的局限性.
主要成果:
- 在NPS类中显著的结构多样性使得通过传统方法进行检测变得复杂.
- 标准临床实验室测试的可变有效性,用于识别不同的NPS.
- 确定了新出现的NPS威胁和加拿大毒品趋势.
结论:
- 改进的毒素监测策略对于加强NPS检测至关重要.
- 解决临床实验室的分析局限性对于有效应对NPS的公共卫生反应至关重要.
- 了解NPS药理和新陈代谢有助于开发更好的检测方法.
更多相关视频
相关概念视频
CNS Stimulants: Psychedelic Agents
133
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
133
Drug Concentrations: Measurements
347
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
347
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Hallucinogens and Psychedelics
160
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
160
An Overview of Psychoactive Drugs
199
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
199
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


